The study, led by Dr. Nolan Williams of Stanford University, enrolled 30 U.S. Special Operations veterans, all supported by VETS through our Foundational Healing Grants program. The results were striking: post-treatment, there was a notable decline in PTSD, anxiety, depression, and an improvement in cognitive function. This groundbreaking research, using ibogaine combined with a cardioprotective agent, showcases a potential new treatment avenue for TBI and associated mental health issues.
Since our founding in 2019, VETS has been a major advocate for veteran mental health, focusing on access to psychedelic-assisted therapies. Our collaboration with Stanford University represents a significant step in validating the effectiveness of ibogaine therapy for PTSD and TBI. The personal accounts of VETS grant recipients captured in the wide range of media reports further reinforce the transformative impact of ibogaine treatment, echoing VETS' mission to provide hope and renewed life to those affected by the traumas of service.
Latest Standford Research News
Smithsonian Magazine: A Lesser-Known Psychedelic Drug Shows Promise for PTSD Treatment
Ibogaine, derived from a central African shrub, has been used in rituals for two millennia. But in a small study, it appeared to reduce symptoms of PTSD among veterans
READ MORE
